Calculation of your study is finished. Please find your results below.

A study for a 68 year old man who takes Losartan Potassium (an AI-powered real world drug study)

Summary:

21,842 males aged 68 (±5) who take the same drug and have adverse effects are studied. This is a phase IV clinical study for a 68 year old male patient who has Hypertension. The study is created by eHealthMe based on reports from sources including the FDA.


On Jan, 21, 2026

21,842 males aged 68 (±5) who take Losartan Potassium and have adverse effects are studied.


Number of reports submitted per year:

Losartan Potassium for a 68-year old man.

Information of the patient in this study:

  • Age: 68
  • Gender: male
  • Conditions: Hypertension
  • Drugs taken:
    • Losartan Potassium (losartan potassium)

Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

  • Hypertension (high blood pressure):
    - among males aged 68 (±5) who take the same drug: 1.02% (222 of 21,842)
    - among people who take the same drug, regardless of gender or age: 1.45% (3,192 of 220,759)

By each condition:


By each drug (FDA data only):

  • people who take Losartan Potassium and have Hypertension:
    - among males aged 68 (±5) who take Losartan Potassium and have side effects: 5.16% (222 of 4,302)
    - among people who take Losartan Potassium and have side effects, regardless of gender or age: 6.38% (3,192 of 50,029)

Common side effects *:

  1. Fatigue (feeling of tiredness): 1,466 people, 6.71%
  2. Diarrhea : 1,209 people, 5.54%
  3. Dyspnea (difficult or laboured breathing): 1,111 people, 5.09%
  4. Weakness : 1,069 people, 4.89%
  5. Nausea (feeling of having an urge to vomit): 956 people, 4.38%
  6. Dizziness : 954 people, 4.37%
  7. Drug Ineffective : 921 people, 4.22%
  8. Acute Kidney Failure : 750 people, 3.43%
  9. Rashes (redness): 745 people, 3.41%
  10. Pneumonia : 689 people, 3.15%
  11. Pain : 678 people, 3.10%
  12. Chest Pain : 665 people, 3.04%
  13. Malaise (a feeling of general discomfort or uneasiness): 643 people, 2.94%
  14. Weight Decreased : 633 people, 2.90%
  15. Cough : 628 people, 2.88%
  16. Fever : 620 people, 2.84%
  17. Joint Pain : 615 people, 2.82%
  18. Hypotension (abnormally low blood pressure): 614 people, 2.81%
  19. Headache (pain in head): 608 people, 2.78%
  20. Death : 592 people, 2.71%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. High Blood Cholesterol : 2,330 people, 10.67%
  2. Diabetes : 1,660 people, 7.60%
  3. Type 2 Diabetes : 1,159 people, 5.31%
  4. Multiple Myeloma (cancer of the plasma cells): 1,144 people, 5.24%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1,129 people, 5.17%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1,093 people, 5.00%
  7. Pain : 1,041 people, 4.77%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 666 people, 3.05%
  9. Cardiac Disorder : 596 people, 2.73%
  10. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 591 people, 2.71%
  11. Depression : 587 people, 2.69%
  12. Psoriasis (immune-mediated disease that affects the skin): 542 people, 2.48%
  13. Prostate Cancer : 504 people, 2.31%
  14. Stress And Anxiety : 467 people, 2.14%
  15. Enlarged Prostate : 421 people, 1.93%
  16. Gout (uric acid crystals building up in the body): 410 people, 1.88%
  17. Hyperlipidaemia (presence of excess lipids in the blood): 407 people, 1.86%
  18. Renal Cell Carcinoma (a kidney cancer): 403 people, 1.85%
  19. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 391 people, 1.79%
  20. Insomnia (sleeplessness): 382 people, 1.75%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Amlodipine (2,822 people, 12.92%)
  2. Metformin (2,752 people, 12.60%)
  3. Aspirin (2,109 people, 9.66%)
  4. Lipitor (1,467 people, 6.72%)
  5. Lasix (1,216 people, 5.57%)
  6. Tamsulosin (1,134 people, 5.19%)
  7. Plavix (1,079 people, 4.94%)
  8. Pantoprazole (1,020 people, 4.67%)
  9. Omeprazole (1,012 people, 4.63%)
  10. Simvastatin (1,006 people, 4.61%)
  11. Vitamin D3 (959 people, 4.39%)
  12. Furosemide (956 people, 4.38%)
  13. Revlimid (895 people, 4.10%)
  14. Clopidogrel (838 people, 3.84%)
  15. Lantus (814 people, 3.73%)
  16. Xarelto (807 people, 3.69%)
  17. Hydrochlorothiazide (791 people, 3.62%)
  18. Crestor (785 people, 3.59%)
  19. Norvasc (766 people, 3.51%)
  20. Nexium (764 people, 3.50%)

Drug effectiveness *:

Losartan Potassium:
  • not at all: 1.28 %
  • somewhat: 14.8 %
  • moderate: 40.94 %
  • high: 33.42 %
  • very high: 9.57 %

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug side effects:

Drugs that are associated with:

Conditions that are associated with:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.